Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma

Genes Chromosomes and Cancer

Volumn 47, Issue 4, 2008, Pages 353-362

  Tan, Kaia Davis ^a   Zhu, Yansong ^a   Hiang, Khoon Tan ^a   Rajasegaran, Vikneswari ^b   Aggarwal, Amit ^a   Wu, Jeanie ^a   Hui, Yong Wu ^a   Hwang, Jacqueline ^c   Lim, Dennis T H ^a   Khee, Chee Soo ^a   Tan, Patrick ^b,d  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b DUKE NUS MEDICAL SCHOOL   (Singapore)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PPFIA1 PROTEIN; PROTEIN TYROSINE PHOSPHATASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL INVASION; CHROMOSOME 11Q; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; PPFIAI1 GENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SUPPRESSOR GENE; UPREGULATION; WOUND HEALING;

EID: 40049096746     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20539     Document Type: Article

References (60)

1. Akervall JA, Jin Y, Wennerberg JP, Zatterstrom UK, Kjellen E, Mertens F, Willen R, Mandahl N, Heim S, Mitelman F. 1995. Chromosomal abnormalities involving 11q13 are associated with poor prognosis in patients with squamous cell carcinoma of the head and neck. Cancer 76: 853–859.
2. Alavi S, Namazie A, Sercarz JA, Wang MB, Blackwell KE. 1999. Distant lymphatic metastasis from head and neck cancer. Ann Otol Rhinol Laryngol 108: 860–863.
3. Ambartsumian NS, Grigorian MS, Larsen IF, Karlstrom O, Sidenius N, Rygaard J, Georgiev G, Lukanidin E. 1996. Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene. Oncogene 13: 1621–1630.
4. Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND, Greenman J. 2003. Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer 89: 864–869.
5. Bockmuhl U, Schluns K, Kuchler I, Petersen S, Petersen I. 2000. Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157: 369–375.
6. Brunin F, Mosseri V, Jaulerry C, Point D, Cosset JM, Rodriguez J. 1999. Cancer of the base of the tongue: past and future. Head Neck 21: 751–759.
7. Chen YJ, Lin SC, Kao T, Chang CS, Hong PS, Shieh TM, Chang KW. 2004. Genome‐wide profiling of oral squamous cell carcinoma. J Pathol 204: 326–332.
8. Davies MP, Rudland PS, Robertson L, Parry EW, Jolicoeur P, Barraclough R. 1996. Expression of the calcium‐binding protein S100A4 (p9Ka) in MMTV‐neu transgenic mice induces metastasis of mammary tumours. Oncogene 13: 1631–1637.
9. Duesberg P, Stindl R, Hehlmann R. 2001. Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy. Proc Natl Acad Sci USA 98: 11283–11288.
10. Dunah AW, Hueske E, Wyszynski M, Hoogenraad CC, Jaworski J, Pak DT, Simonetta A, Liu G, Sheng M. 2005. LAR receptor protein tyrosine phosphatases in the development and maintenance of excitatory synapses. Nat Neurosci 8: 458–467.
11. Forastiere A, Koch W, Trotti A, Sidransky D. 2001. Head and neck cancer. N Engl J Med 345: 1890–1900.
12. Fortin A, Guerry M, Guerry R, Talbot M, Parise O, Schwaab G, Bosq J, Bourhis J, Salvatori P, Janot F, Busson P. 1997. Chromosome 11q13 gene amplifications in oral and oropharyngeal carcinomas: No correlation with subclinical lymph node invasion and disease recurrence. Clin Cancer Res 3: 1609–1614.
13. Freier K, Sticht C, Hofele C, Flechtenmacher C, Stange D, Puccio L, Toedt G, Radlwimmer B, Lichter P, Joos S. 2006. Recurrent coamplification of cytoskeleton‐associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma. Genes Chromosomes Cancer 45: 118–125.
14. Garnis C, Campbell J, Zhang L, Rosin MP, Lam WL. 2004. OCGR array: An oral cancer genomic regional array for comparative genomic hybridization analysis. Oral Oncol 40: 511–519.
15. Gebhart E, Ries J, Wiltfang J, Liehr T, Efferth T. 2004. Genomic gain of the epidermal growth factor receptor harboring band 7p12 is part of a complex pattern of genomic imbalances in oral squamous cell carcinomas. Arch Med Res 35: 385–394.
16. Goessel G, Quante M, Hahn WC, Harada H, Heeg S, Suliman Y, Doebele M, von Werder A, Fulda C, Nakagawa H, Rustgi AK, Blum HE, Opitz OG. 2005. Creating oral squamous cancer cells: A cellular model of oral‐esophageal carcinogenesis. Proc Natl Acad Sci USA 102: 15599–15604.
17. Gollin SM. 2001. Chromosomal alterations in squamous cell carcinomas of the head and neck: Window to the biology of disease. Head Neck 23: 238–253.
18. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. 1999. Creation of human tumour cells with defined genetic elements. Nature 400: 464–468.
19. Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schaffer AA, Desper R, Schantz SP. 2002. Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: Construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34: 224–233.
20. Huang X, Godfrey TE, Gooding WE, McCarty KS, Jr., Gollin SM. 2006. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma. Genes Chromosomes Cancer 45: 1058–1069.
21. Hutchinson JN, Jin J, Cardiff RD, Woodgett JR, Muller WJ. 2004. Activation of Akt‐1 (PKB‐α) can accelerate ErbB‐2‐mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res 64: 3171–3178.
22. Ishkanian AS, Malloff CA, Watson SK, DeLeeuw RJ, Chi B, Coe BP, Snijders A, Albertson DG, Pinkel D, Marra MA, Ling V, MacAulay C, Lam WL. 2004. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 36: 299–303.
23. Jarvinen AK, Autio R, Haapa‐Paananen S, Wolf M, Saarela M, Grenman R, Leivo I, Kallioniemi O, Makitie AA, Monni O. 2006. Identification of target genes in laryngeal squamous cell carcinoma by high‐resolution copy number and gene expression microarray analyses. Oncogene 25: 6997–7008.
24. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. 2005. Cancer statistics 2005. CA Cancer J Clin 55: 10–30.
25. Jin Y, Hoglund M, Jin C, Martins C, Wennerberg J, Akervall J, Mandahl N, Mitelman F, Mertens F. 1998. FISH characterization of head and neck carcinomas reveals that amplification of band 11q13 is associated with deletion of distal 11q. Genes Chromosomes Cancer 22: 312–320.
26. Katoh M, Katoh M. 2003. Evolutionary conservation of CCND1‐ORAOV1‐FGF19‐FGF4 locus from zebrafish to human. Int J Mol Med 12: 45–50.
27. Kaufmann N, DeProto J, Ranjan R, Wan H, Van Vactor D. 2002. Drosophila liprin‐α and the receptor phosphatase Dlar control synapse morphogenesis. Neuron 34: 27–38.
28. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. 2006. Cyclin D1: Polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620–1628.
29. Ko J, Kim S, Valtschanoff JG, Shin H, Lee JR, Sheng M, Premont RT, Weinberg RJ, Kim E. 2003. Interaction between liprin‐α and GIT1 is required for AMPA receptor targeting. J Neurosci 23: 1667–1677.
30. Kriajevska M, Fischer‐Larsen M, Moertz E, Vorm O, Tulchinsky E, Grigorian M, Ambartsumian N, Lukanidin E. 2002. Liprin β 1, a member of the family of LAR transmembrane tyrosine phosphatase‐interacting proteins, is a new target for the metastasis‐associated protein S100A4 (Mts1). J Biol Chem 277: 5229–5235.
31. Lese CM, Rossie KM, Appel BN, Reddy JK, Johnson JT, Myers EN, Gollin SM. 1995. Visualization of INT2 and HST1 amplification in oral squamous cell carcinomas. Genes Chromosomes Cancer 12: 288–295.
32. Lin M, Smith LT, Smiraglia DJ, Kazhiyur‐Mannar R, Lang JC, Schuller DE, Kornacker K, Wenger R, Plass C. 2006. DNA copy number gains in head and neck squamous cell carcinoma. Oncogene 25: 1424–1433.
33. Manabe R, Kovalenko M, Webb DJ, Horwitz AR. 2002. GIT1 functions in a motile, multi‐molecular signaling complex that regulates protrusive activity and cell migration. J Cell Sci 115: 1497–1510.
34. Matzke MA, Mette MF, Kanno T, Matzke AJ. 2003. Does the intrinsic instability of aneuploid genomes have a causal role in cancer? Trends Genet 19: 253–256.
35. Meredith SD, Levine PA, Burns JA, Gaffey MJ, Boyd JC, Weiss LM, Erickson NL, Williams ME. 1995. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch Otolaryngol Head Neck Surg 121: 790–794.
36. Miller KE, DeProto J, Kaufmann N, Patel BN, Duckworth A, Van Vactor D. 2005. Direct observation demonstrates that Liprin‐alpha is required for trafficking of synaptic vesicles. Curr Biol 15: 684–689.
37. Mineta H, Miura K, Takebayashi S, Ueda Y, Misawa K, Harada H, Wennerberg J, Dictor M. 2000. Cyclin D1 overexpression correlates with poor prognosis in patients with tongue squamous cell carcinoma. Oral Oncol 36: 194–198.
38. Mork J. 1998. Forty years of monitoring head and neck cancer in Norway—No good news. Anticancer Res 18: 3705–3708.
39. Muller D, Millon R, Velten M, Bronner G, Jung G, Engelmann A, Flesch H, Eber M, Methlin G, Abecassis J. 1997. Amplification of 11q13 DNA markers in head and neck squamous cell carcinomas: Correlation with clinical outcome. Eur J Cancer 33: 2203–2210.
40. Nagpal JK, Das BR. 2003. Oral cancer: Reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 39: 213–221.
41. Nowak MA, Komarova NL, Sengupta A, Jallepalli PV, Shih Ie M, Vogelstein B, Lengauer C. 2002. The role of chromosomal instability in tumor initiation. Proc Natl Acad Sci USA 99: 16226–16231.
42. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics 2002. CA Cancer J Clin 55: 74–108.
43. Rasband WS. ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij/, 1997–2007.
44. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM. 2004. ONCOMINE: A cancer microarray database and integrated data‐mining platform. Neoplasia 6: 1–6.
45. Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suarez C. 2000. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 6: 3177–3182.
46. Schuuring E. 1995. The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes—A review. Gene 159: 83–96.
47. Serra‐Pages C, Kedersha NL, Fazikas L, Medley Q, Debant A, Streuli M. 1995. The LAR transmembrane protein tyrosine phosphatase and a coiled‐coil LAR‐interacting protein co‐localize at focal adhesions. EMBO J 14: 2827–2838.
48. Serra‐Pages C, Medley QG, Tang M, Hart A, Streuli M. 1998. Liprins, a family of LAR transmembrane protein‐tyrosine phosphatase‐interacting proteins. J Biol Chem 273: 15611–15620.
49. Shen JC, Unoki M, Ythier D, Duperray A, Varticovski L, Kumamoto K, Pedeux R, Harris CC. 2007. Inhibitor of growth 4 suppresses cell spreading and cell migration by interacting with a novel binding partner, liprin α1. Cancer Res 67: 2552–2558.
50. Silverman S, Jr. 1990. Oral complications of cancer therapies. Oral defenses and compromises: An overview. NCI Monogr 9: 17–19.
51. Squire JA, Bayani J, Luk C, Unwin L, Tokunaga J, MacMillan C, Irish J, Brown D, Gullane P, Kamel‐Reid S. 2002. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis. Head Neck 24: 874–887.
52. Stal O, Perez‐Tenorio G, Akerberg L, Olsson B, Nordenskjold B, Skoog L, Rutqvist LE. 2003. Akt kinases in breast cancer and the results of adjuvant therapy. Breast Cancer Res 5: R37–R44.
53. Takenaga K, Nakamura Y, Endo H, Sakiyama S. 1994. Involvement of S100‐related calcium‐binding protein pEL98 (or mts1) in cell motility and tumor cell invasion. Jpn J Cancer Res 85: 831–839.
54. Unoki M, Shen JC, Zheng ZM, Harris CC. 2006. Novel splice variants of ING4 and their possible roles in the regulation of cell growth and motility. J Biol Chem 281: 34677–34686.
55. Veltman JA, Schoenmakers EF, Eussen BH, Janssen I, Merkx G, van Cleef B, van Ravenswaaij CM, Brunner HG, Smeets D, van Kessel AG. 2002. High‐throughput analysis of subtelomeric chromosome rearrangements by use of array‐based comparative genomic hybridization. Am J Hum Genet 70: 1269–1276.
56. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK. 1993. Head and neck cancer. N Engl J Med 328: 184–194.
57. Wreesmann VB, Shi W, Thaler HT, Poluri A, Kraus DH, Pfister D, Shaha AR, Shah JP, Rao PH, Singh B. 2004. Identification of novel prognosticators of outcome in squamous cell carcinoma of the head and neck. J Clin Oncol 22: 3965–3972.
58. Yoeli‐Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A. 2005. Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 20: 539–550.
59. Yu Z, Weinberger PM, Haffty BG, Sasaki C, Zerillo C, Joe J, Kowalski D, Dziura J, Camp RL, Rimm DL, Psyrri A. 2005. Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. Clin Cancer Res 11: 1160–1166.
60. Zhen M, Jin Y. 1999. The liprin protein SYD‐2 regulates the differentiation of presynaptic termini in C. elegans. Nature 401: 371–375.